IRIS
SANTILLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.488
EU - Europa 6.667
AS - Asia 6.300
SA - Sud America 804
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 23.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.287
SG - Singapore 2.616
CN - Cina 1.646
RU - Federazione Russa 1.420
IE - Irlanda 953
IT - Italia 894
UA - Ucraina 787
TR - Turchia 702
SE - Svezia 698
BR - Brasile 653
VN - Vietnam 606
GB - Regno Unito 567
DE - Germania 414
FR - Francia 404
IN - India 266
FI - Finlandia 251
HK - Hong Kong 113
CA - Canada 103
AR - Argentina 69
MX - Messico 68
PL - Polonia 65
JP - Giappone 49
NL - Olanda 47
BD - Bangladesh 45
IQ - Iraq 42
ZA - Sudafrica 36
AT - Austria 35
ES - Italia 29
ID - Indonesia 28
KR - Corea 25
PK - Pakistan 23
CZ - Repubblica Ceca 18
EC - Ecuador 17
BE - Belgio 16
MA - Marocco 16
VE - Venezuela 16
SA - Arabia Saudita 14
AZ - Azerbaigian 13
CL - Cile 13
LT - Lituania 12
UZ - Uzbekistan 12
EU - Europa 11
IR - Iran 11
AL - Albania 10
CO - Colombia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
PH - Filippine 9
DZ - Algeria 8
PY - Paraguay 8
RO - Romania 8
LB - Libano 7
PE - Perù 7
EG - Egitto 6
NG - Nigeria 6
OM - Oman 6
QA - Qatar 6
UY - Uruguay 6
ET - Etiopia 5
JM - Giamaica 5
KE - Kenya 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
GR - Grecia 4
HU - Ungheria 4
NI - Nicaragua 4
NP - Nepal 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BZ - Belize 3
CR - Costa Rica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KH - Cambogia 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
EE - Estonia 1
Totale 23.358
Salva come PNG Salva come JPEG
Città #
Singapore 2.024
San Jose 1.094
Chandler 1.086
Jacksonville 959
Dublin 939
Ashburn 846
Dallas 525
Beijing 446
Princeton 383
Southend 370
Izmir 335
Los Angeles 255
Nanjing 235
Santa Clara 225
Ho Chi Minh City 207
Dearborn 205
The Dalles 192
Wilmington 186
New York 173
Cambridge 159
Ann Arbor 144
Hanoi 142
Altamura 134
Chieti 107
Munich 105
Moscow 103
Hong Kong 101
Nanchang 99
Tongling 99
Council Bluffs 92
Boardman 90
Buffalo 86
Pescara 81
São Paulo 70
Washington 64
Helsinki 61
Orem 59
Redondo Beach 57
Brooklyn 49
Shenyang 49
Hebei 48
Kunming 47
Montreal 47
Tokyo 46
Woodbridge 44
Tianjin 42
Rome 38
Warsaw 38
Turku 34
Denver 33
Chennai 32
Changsha 31
Jiaxing 31
Stockholm 31
Frankfurt am Main 30
Grevenbroich 30
Seattle 30
Hefei 29
Milan 29
Norwalk 29
Chicago 28
London 28
Poplar 28
Augusta 27
Johannesburg 27
Mexico City 26
Toronto 25
Atlanta 24
Amsterdam 23
Da Nang 23
Seoul 23
Nuremberg 22
Houston 21
Manchester 20
Ankara 19
San Francisco 19
Boston 18
Dong Ket 18
Jinan 18
Shanghai 18
Changchun 17
Lanzhou 17
Mumbai 17
Phoenix 17
San Mateo 17
Brussels 16
Hangzhou 16
Rio de Janeiro 16
Falls Church 15
Vienna 15
Baghdad 14
Belo Horizonte 14
Brno 14
Guangzhou 14
Haiphong 14
Querétaro 14
St Louis 13
Baku 12
Brasília 12
Paris 12
Totale 14.106
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 826
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 180
Pentraxin 3 and platelet activation in obese patients after gastric banding 179
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 171
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 166
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 161
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 161
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 161
Role of growth factors in the development of diabetic complications 157
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 155
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 154
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 154
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 153
Determinants of platelet activation in hypertensives with microalbuminuria. 152
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 151
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 149
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 144
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 144
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 143
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 143
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 142
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 142
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 141
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 141
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 140
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 140
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 140
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 139
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Platelets and Diabetes 138
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 138
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 137
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 136
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 135
Neurocognitive impairment and suicide risk among prison inmates 135
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 135
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 134
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 133
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 132
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 132
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 132
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 132
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 132
Platelet activation in obesity and metabolic syndrome. 131
Platelets and diabetes mellitus 131
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 131
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 131
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 130
Aspirin, platelets, and cancer: The point of view of the internist. 130
Insulin resistance as a determinant of platelet activation in obese women. 129
Coagulation and infective endocarditis: sooner or later 129
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 129
The role of antileukotrienes in the treatment of asthma. 128
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 128
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 127
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 127
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 127
COVID-19 and RAS: Unravelling an Unclear Relationship 127
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 127
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 126
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 126
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 125
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 125
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 125
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 124
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 124
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 124
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 124
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 124
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 123
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 122
Determinants of platelet activation in hypertensives with microalbuminuria. 121
The role of nitric oxide in the development of diabetic angiopathy. 120
Association between PAI-1 and Oxidative Stress in Android Obesity 120
Soluble forms of RAGE in internal medicine. 120
Soluble RAGE in type 2 diabetes: association with oxidative stress. 119
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 119
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 119
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 118
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 117
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 117
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study 117
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 116
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 116
Atherothrombotic disease and the metabolic syndrome. 115
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 115
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 115
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 115
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 112
Aspirin as antiplatelet agent in diabetes. PROS-. 112
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 111
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 111
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 111
I biomarcatori nella stratificazione del rischio. Cosa aggiungono nella gestione del paziente. 111
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 111
Insulin resistance as a determinant of platelet activation in obese women 110
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 110
Totale 13.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 0 0 0 0 0 0 0 140 38 36
2021/20221.005 29 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.743 242 703 577 88 92 172 144 172 350 174 451 578
2025/20268.598 651 337 908 1.086 901 462 1.451 470 1.560 772 0 0
Totale 24.502